Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-1251-2014

Drug recall · April 30, 2014

VPRIV¿ (velaglucerase alfa for injection) recall

Why: Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.

Lots / codes

US: Lot #: FEW13-001, FEW13-002, FED13-006; Expiry: 10/15. Mexico: Lot #: FED 013-010; Expiry: 10/15. Columbia: Lot #: FED 013-011; Expiry: 10/15.

Quantity
8359 vials
Company
Shire Human Genetic Therapies, Inc., Lexington, MA
Distribution
US Nationwide including Puerto Rico; Mexico, Columbia
Initiated
March 14, 2014 · Voluntary: Firm initiated
Classified
April 18, 2014
Reported
April 30, 2014
Ended
August 31, 2016
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.